Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background/aim: The role of tumour-infiltrating CD45Ro T-cells in oral squamous cell carcinoma (OSCC) is unclear. This study aimed to evaluate prognostic biomarkers for OSCC.
Patients And Methods: We determined the density of tumour-infiltrating CD45Ro T cells in the parenchyma and stroma at the tumour centre (TCe) and invasive front (IF) and examined the association between the density of these cells and histopathological status in 142 patients.
Results: Five-year overall survival (OS) and recurrence-free survival were favourable in patients with high CD45Ro T-cell density in the TCe stroma. OS was favourable in patients with high CD45Ro T-cell density in the IF stroma. Stepwise Cox regression model analysis indicated that CD45Ro T-cells in the stroma of the IF and TCe were an independent prognostic factor for OS.
Conclusion: CD45Ro T-cells in the stroma of the IF and TCe play a role in cancer immune surveillance and may be a useful prognostic factor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.15262 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
T-cell receptor repertoire and HLA in osteoarthritis: A systematic literature review.
Osteoarthritis Cartilage
September 2025
Immunology, Immunopathology, Immunotherapy I3 Lab, Inserm UMRS 959, Sorbonne Université, Paris, France; Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Electronic address: encarnita.mariotti@sorbonne-u
Objective: The aim of this systematic literature review was to provide a comprehensive overview of T-Cell Receptor (TCR) mediated immunity research in osteoarthritis (OA).
Design: The search was conducted in April 2024 on PubMed and Embase, following PRISMA 2020. Search was primarily based on MeSH terms, free-text was used when required.
PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity.
Sci Adv
September 2025
Department of Medicine, Altman Clinical and Translational Research Institute, University of California, San Diego, La Jolla, CA 92093, USA.
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is encoded by a gene strongly associated with lupus and other autoimmune diseases. PTPN22 regulates T cell receptor (TCR) signaling through dephosphorylation of the kinases lymphocyte-specific protein tyrosine kinase (LCK) and zeta-chain-associated protein kinase 70 (ZAP70). The regulation of PTPN22 remains poorly understood.
View Article and Find Full Text PDFImmunophenotyping of apparently immunocompetent hosts with cryptococcosis reveals IL-17 deficiency as a unifying susceptibility factor.
Clin Exp Immunol
August 2025
Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
Introduction: We describe the immunophenotyping and genetic analysis of HIV-uninfected apparently immunocompetent adults presenting with disseminated cryptococcosis. Cryptococci are environmentally ubiquitous fungi that may cause disseminated infection including meningitis. Cryptococcosis occurs predominantly in immunocompromised hosts and most commonly in the context of human immunodeficiency virus (HIV) infection.
View Article and Find Full Text PDFCorrelation With Dysplasia Severity and Malignant Potential of CD45RO T Cell Density in OLP and OED.
Oral Dis
August 2025
Department of Stomatology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Objective: This study investigates the role of CD45RO T cell densities in Oral lichen planus (OLP) and oral epithelial dysplasia with lichenoid features (OED), examining their distribution across different disease stages and their implications for disease progression and malignancy risk.
Methods: Histopathological evaluation of 71 tissue samples identified 56 cases of OLP and 15 cases of OED. Subsequent analyses focused on the immunohistochemical expression of CD45RO.
Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases.
Int J Mol Sci
July 2025
Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
Stage IV colorectal cancer has a poor prognosis, and liver metastases are prone to recurrence, even after resection. This study aimed to identify common cancer antigens, using immunohistochemical staining, as promising targets for antigen-specific immunotherapies in colorectal cancer. We analyzed expression levels and intracellular localization of seven common cancer antigens, CLDN1, EphB4, LAT1, FOXM1, HSP105α, ROBO1, and SPARC, and human leukocyte antigen (HLA) class I via immunohistochemical staining of 85 surgical specimens from primaries and liver metastases.
View Article and Find Full Text PDF